Search

everythinglearnresearchcommunity

for

Search:↓

Rapamycin treatment helps reduce brain inflammation and symptoms of mitochondrial disease by blocking specific pathways in mice.

Keratin 6A increases skin inflammation, suggesting it could be a target for treating certain skin diseases.

STAT3 signaling is important for healthy skin and hair follicles, and its disruption can lead to skin conditions like atopic dermatitis.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

ILK and ELMO2 help cells move and stick together, important for wound healing and hair growth.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

The enzymes Tet1, Tet2, and Tet3 are important for the development of hair follicles and determining hair shape by controlling hair keratin genes.

Reduced cytokinin levels help plants adapt to low potassium by increasing root hair growth and potassium uptake.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

JAK/STAT1 pathway causes hair loss during chemotherapy by reducing Shh in hair follicles.

miR-3606-3p reduces skin fibrosis by blocking key signaling pathways.

Removing a methyl group from the ITGAV gene speeds up bone formation in a specific type of bone disease model.

Keloid scars may form due to changes in skin cell characteristics and specific protein signaling.

TLR3 activation helps improve skin and hair follicle healing in mice.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

The study found a specific peptide that helps detect TGase 3 activity in skin and hair follicles.

Kv1.3 blockers may help treat alopecia areata and promote hair regrowth.

ILK is essential for proper hair follicle development and structure.

The enzyme is crucial for skin cell development and can be activated without proteolytic activation.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Antizyme slows skin tumor growth by reducing cell growth in mice.

TAF4 is important for skin cell growth and helps prevent skin cancer in mice.

CIPK13 and CIPK18 genes are crucial for root hair growth in plants.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Blocking Wnt signaling in young mice causes thymus shrinkage and cell loss, but recovery is possible when the block is removed.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.